These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 8117665

  • 1. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.
    Nguyen Q, Willenbrock F, Cockett MI, O'Shea M, Docherty AJ, Murphy G.
    Biochemistry; 1994 Mar 01; 33(8):2089-95. PubMed ID: 8117665
    [Abstract] [Full Text] [Related]

  • 2. Structure-function relationships in the tissue inhibitors of metalloproteinases.
    Willenbrock F, Murphy G.
    Am J Respir Crit Care Med; 1994 Dec 01; 150(6 Pt 2):S165-70. PubMed ID: 7952654
    [Abstract] [Full Text] [Related]

  • 3. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A.
    Willenbrock F, Crabbe T, Slocombe PM, Sutton CW, Docherty AJ, Cockett MI, O'Shea M, Brocklehurst K, Phillips IR, Murphy G.
    Biochemistry; 1993 Apr 27; 32(16):4330-7. PubMed ID: 8476862
    [Abstract] [Full Text] [Related]

  • 4. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM.
    Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829
    [Abstract] [Full Text] [Related]

  • 5. Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions.
    Butler GS, Apte SS, Willenbrock F, Murphy G.
    J Biol Chem; 1999 Apr 16; 274(16):10846-51. PubMed ID: 10196161
    [Abstract] [Full Text] [Related]

  • 6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J.
    J Neurosurg; 1995 Aug 16; 83(2):298-307. PubMed ID: 7616276
    [Abstract] [Full Text] [Related]

  • 7. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP).
    Shapiro SD, Fliszar CJ, Broekelmann TJ, Mecham RP, Senior RM, Welgus HG.
    J Biol Chem; 1995 Mar 17; 270(11):6351-6. PubMed ID: 7890773
    [Abstract] [Full Text] [Related]

  • 8. Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin.
    Baragi VM, Fliszar CJ, Conroy MC, Ye QZ, Shipley JM, Welgus HG.
    J Biol Chem; 1994 Apr 29; 269(17):12692-7. PubMed ID: 8175679
    [Abstract] [Full Text] [Related]

  • 9. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
    Schmitz JP, Dean DD, Schwartz Z, Cochran DL, Grant GM, Klebe RJ, Nakaya H, Boyan BD.
    J Cell Biochem; 1996 Jun 01; 61(3):375-91. PubMed ID: 8761942
    [Abstract] [Full Text] [Related]

  • 10. Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1.
    Crabbe T, Zucker S, Cockett MI, Willenbrock F, Tickle S, O'Connell JP, Scothern JM, Murphy G, Docherty AJ.
    Biochemistry; 1994 May 31; 33(21):6684-90. PubMed ID: 7911325
    [Abstract] [Full Text] [Related]

  • 11. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
    Will H, Atkinson SJ, Butler GS, Smith B, Murphy G.
    J Biol Chem; 1996 Jul 19; 271(29):17119-23. PubMed ID: 8663332
    [Abstract] [Full Text] [Related]

  • 12. Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant.
    Murphy G, Nguyen Q, Cockett MI, Atkinson SJ, Allan JA, Knight CG, Willenbrock F, Docherty AJ.
    J Biol Chem; 1994 Mar 04; 269(9):6632-6. PubMed ID: 8120015
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2.
    Bigg HF, Shi YE, Liu YE, Steffensen B, Overall CM.
    J Biol Chem; 1997 Jun 13; 272(24):15496-500. PubMed ID: 9182583
    [Abstract] [Full Text] [Related]

  • 15. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis.
    Rifas L, Fausto A, Scott MJ, Avioli LV, Welgus HG.
    Endocrinology; 1994 Jan 13; 134(1):213-21. PubMed ID: 8275936
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma.
    Moutsiakis D, Mancuso P, Krutzsch H, Stetler-Stevenson W, Zucker S.
    Connect Tissue Res; 1992 Jan 13; 28(3):213-30. PubMed ID: 1468208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.